The pharmaceuticals sector in Texas thrives on innovation, delivering solutions for health challenges ranging from chronic diseases to critical care. The industry includes biopharmaceutical companies, manufacturers, and research organizations focused on developing new drugs and treatments across multiple specializations. Advances in biotechnology and personalized medicine are driving growth, while a collaborative ecosystem fostered by academic institutions attracts significant investment. Texas is poised to become a pivotal hub for drug development, leveraging cutting-edge research and a skilled workforce to meet both domestic and international healthcare needs. This trajectory highlights the state’s significance in shaping the future of healthcare delivery.

The following companies within this list showcase a range of healthcare specializations and product offerings. Most companies operate at a mid-sized scale, employing between 11 to 500 staff members. Founded from the mid-1980s to recent years, they focus variously on areas like oncology, women’s health, and personalized medicine. Headquarters span cities including Houston, Dallas, Austin, and San Antonio. Each company plays a vital role in developing innovative pharmaceutical products, making significant contributions to patient care. This collective growth reflects Texas’s dynamic position in the pharmaceuticals market.

Continue reading to explore Texas's top pharmaceuticals companies.

Top 25 Pharmaceuticals Companies Companies in Texas

1. Neos Therapeutics, Inc.

• Website: neostx.com
• Ownership type: Corporate
• Headquarters: Grand Prairie, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $44.9M, December 2020
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: neos-therapeutics

Neos Therapeutics, Inc. is a pharmaceutical company based in Grand Prairie, Texas, founded in 2008. The company specializes in innovative prescription therapeutics aimed at treating Attention Deficit Hyperactivity Disorder (ADHD) and addressing pediatric health needs. Neos Therapeutics is dedicated to developing and commercializing products that enhance patient wellness, focusing on both consumers and healthcare providers. Their product portfolio includes several medications for ADHD, such as ADZENYS XR-ODT and COTEMPLA XR-ODT, as well as pediatric products like Karbinal ER, which treats allergic conditions. The company operates with a patient-first philosophy, offering support programs to improve treatment accessibility. In December 2020, Neos Therapeutics secured $44.9 million in funding, reflecting their active engagement in the pharmaceutical industry and commitment to expanding their product offerings.

2. Orano Med

• Website: oranomed.com
• Ownership type: Private
• Headquarters: Plano, Texas, United States (USA)
• Employee distribution: France 55%, United States (USA) 42%, Other 2%
• Founded year: 2009
• Headcount: 51-200
• LinkedIn: areva-med-llc

Orano Med, founded in 2009 and based in Plano, Texas, is a biotechnology firm dedicated to the development of targeted therapies for cancer. The company specializes in using lead-212, a rare alpha-emitting radioisotope, to create innovative treatments aimed at addressing significant unmet medical needs in oncology. Orano Med operates with a clear mission to make targeted alpha therapy a reality, focusing on developing a robust pipeline of 212Pb-based therapies and ensuring a reliable supply chain for these drugs. They have established preclinical laboratories in both the United States and France, and are currently conducting clinical trials for their therapies. With a team of approximately 172 employees, Orano Med is positioned to contribute meaningfully to the field of cancer treatment, particularly through their unique approach to radioligand therapy.

3. Radiomedix, Inc.

• Website: radiomedix.com
• Ownership type: Private Equity
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $40.0M, October 2022
• Founded year: 2006
• Headcount: 11-50
• LinkedIn: radiomedix-inc-

Radiomedix, Inc. is a clinical-stage biotechnology firm based in Houston, Texas, founded in 2006. The company is dedicated to developing innovative targeted radiopharmaceuticals aimed at improving cancer diagnosis and therapy. Radiomedix offers a comprehensive suite of services that spans from drug discovery to commercial-scale manufacturing, ensuring compliance with regulatory standards for clinical trials. Their operations include the development of radiopharmaceuticals for PET imaging and targeted therapies, which are crucial for precise cancer treatment. The company has established facilities that meet stringent cGMP guidelines, enabling them to support both academic and industrial partners in their clinical research endeavors. Recently, Radiomedix secured $40 million in Series A funding, reflecting strong investor interest in their pipeline and capabilities. Their commitment to advancing nuclear medicine is evident through their ongoing projects and collaborations, including a licensing agreement with Sanofi for next-generation radioligand medicine.

4. Peloton Therapeutics

• Website: pelotontherapeutics.com
• Ownership type: Corporate
• Headquarters: Dallas, Texas, United States (USA)
• Latest funding: May 2019
• Founded year: 2011
• Headcount: 11-50
• LinkedIn: peloton-therapeutics

Peloton Therapeutics, Inc., based in Dallas, Texas, is a clinical stage pharmaceutical company founded in 2011. The company is dedicated to translating novel scientific insights into first-in-class medicines aimed at treating cancer and other serious diseases. Peloton is particularly focused on HIF-2α, a transcription factor that has been challenging to target with small molecules. They have made significant strides in this area, being the first to bring a HIF-2α-targeting drug into clinical development. Their research and development efforts are centered on discovering new compounds that can effectively modulate complex protein-protein interactions involved in disease processes. Peloton's work has the potential to transform treatment paradigms for conditions such as kidney cancer and VHL Disease, making them a notable player in the pharmaceutical industry.

5. Remus Pharmaceuticals Limited

• Website: remuspharma.com
• Ownership type: Private
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: India 97%, United States (USA) 3%
• Founded year: 2015
• Headcount: 201-500
• LinkedIn: remus-pharmaceuticals-pvt--ltd-

Remus Pharmaceuticals Limited, based in Austin, Texas, is a private pharmaceutical company founded in 2015. The company specializes in the marketing of innovative medicinal products and generic drugs, catering to a wide range of therapeutic areas such as oncology, dermatology, cardiovascular health, and diabetes management. With a robust portfolio of over 600 products, Remus aims to provide effective and affordable healthcare solutions to healthcare providers and pharmacies. The company operates with a strong emphasis on quality, supported by a proficient regulatory team that ensures compliance with global standards. Remus has established manufacturing facilities in both the USA and India, allowing them to produce a variety of dosage forms, including tablets, capsules, and injectables. Their commitment to addressing unmet medical needs and their strategic focus on market research for product development position them as a notable player in the pharmaceutical industry.

6. GM Pharmaceuticals, Inc.

• Website: gmpharm.net
• Ownership type: Private
• Headquarters: Fort Worth, Texas, United States (USA)
• Employee distribution: United States (USA) 25%, Georgia 25%, India 25%, Other 25%
• Founded year: 1991
• Headcount: 11-50
• LinkedIn: gmpharm

GM Pharmaceuticals, Inc., based in Fort Worth, Texas, has been a player in the pharmaceutical industry since its founding in 1991. The company focuses on developing and selling a variety of health products, with a particular emphasis on allergy relief medications and solutions for children's health. GM Pharmaceuticals aims to provide effective and affordable options for families, addressing common health issues with its patented formulas. The company operates in multiple therapeutic areas, including over-the-counter medications and supplements, and has a notable presence in the allergy relief market with its TexaClear brand. GM Pharmaceuticals is committed to quality and innovation, continuously working to enhance its product offerings and maintain safety standards for consumers. With a workforce of around 22 employees and a global reach that includes operations in the United States, India, Georgia, and Armenia, GM Pharmaceuticals is positioned to meet the needs of its target market effectively.

7. Evestra, Inc.

• Website: evestra.com
• Ownership type: Private
• Headquarters: Schertz, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Convertible note, $1.8M, December 2009
• Founded year: 2020
• Headcount: 11-50
• LinkedIn: evestra-inc.

Evestra, Inc. is a private biopharmaceutical company based in Schertz, Texas, founded in 2020. The company specializes in developing innovative products aimed at improving women's health. Their focus areas include fertility control, endometriosis, hormone replacement therapy, and oncology. Evestra employs advanced medicinal chemistry and drug delivery technologies to create solutions that address significant health challenges faced by women. The company operates two facilities in the San Antonio area, one dedicated to research and development and the other for commercial production of vaginal ring products. Evestra's product pipeline includes both pre-clinical and clinical-stage products, and they hold numerous patents to protect their innovations. Notably, Evestra has received funding from the Bill and Melinda Gates Foundation to develop a long-acting injectable contraceptive, highlighting their commitment to enhancing access to women's health solutions globally.

8. Mission Pharmacal

• Website: missionpharmacal.com
• Ownership type: Corporate
• Headquarters: San Antonio, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: May 2019
• Founded year: 1946
• Headcount: 201-500
• LinkedIn: mission-pharmacal

Mission Pharmacal Company, based in San Antonio, Texas, has been a significant player in the pharmaceutical industry since its founding in 1946. The company focuses on developing and manufacturing high-quality prescription and over-the-counter products. Its primary therapeutic areas include women's health, urology, and dermatology, where it offers a range of innovative solutions. Mission Pharmacal is known for its CitraNatal line of prenatal vitamins, as well as products like Uribel for urological health and AVAR for dermatological care. The company operates with a commitment to quality, utilizing state-of-the-art manufacturing methods and pure ingredients. With a workforce of approximately 254 employees, Mission Pharmacal continues to serve healthcare providers, pharmacies, and patients across the United States, ensuring that it meets the evolving needs of the healthcare market.

9. Infallible Pharma

• Website: infalliblepharma.com
• Ownership type: Private
• Headquarters: Richmond, Texas, United States (USA)
• Employee distribution: India 100%
• Founded year: 2006
• Headcount: 1-10
• LinkedIn: infallible-pharma

Infallible Pharma, founded in 2006 and based in Richmond, Texas, is a private pharmaceutical manufacturer that specializes in injectable drugs and healthcare products. The company primarily serves hospitals and healthcare institutions, providing essential medications that are crucial for patient care. With a strong commitment to quality and accessibility, Infallible Pharma aims to enhance healthcare delivery across various regions. The company has established manufacturing units that hold WHO-GMP accreditations, ensuring that their products meet international quality standards. Infallible Pharma is actively pursuing international regulatory approvals to expand its presence in markets such as Cambodia, Kenya, Nigeria, Sri Lanka, and Yemen. Their product range includes a variety of pharmaceutical injections and infusions, catering to critical care needs. The company is also focused on research and development, aspiring to innovate and improve drug delivery systems. With a dedicated team of industry professionals, Infallible Pharma is committed to improving patient outcomes through high-quality healthcare solutions.

10. Tvardi Therapeutics

• Website: tvardi.com
• Ownership type: Private
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2017
• Headcount: 1-10
• LinkedIn: tvardi

Tvardi Therapeutics is a private, clinical-stage biopharmaceutical company based in Houston, Texas, founded in 2017. The company is dedicated to developing novel oral small molecule therapies targeting STAT3, a protein implicated in cancer and fibrotic diseases. Their primary product, TTI-101, is currently in multiple clinical trials, including studies focused on liver cancer and idiopathic pulmonary fibrosis (IPF). Tvardi aims to provide effective treatments for conditions that currently lack adequate therapeutic options. The company is led by a team of experienced professionals from the fields of medicine and biotechnology, and it has garnered attention for its innovative approach to tackling significant health challenges. With a focus on clinical development and a commitment to addressing unmet medical needs, Tvardi Therapeutics is positioned as a noteworthy player in the biopharmaceutical industry.

11. ImmunoGenesis, Inc.

• Website: immunogenesis.com
• Ownership type: Venture Capital
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: December 2020
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: immunogenesis-inc

ImmunoGenesis, Inc., founded in 2019 and based in Houston, Texas, is a biopharmaceutical company dedicated to advancing cancer treatment through innovative immuno-oncology therapies. The company specializes in developing therapies for cold tumors, which are characterized by a lack of activated T cells and other immune resistance mechanisms. Their lead products include IMGS-001, a dual-specific PD-L1/PD-L2 inhibitor designed to enhance immune response in these challenging cases, and IMGS-101, a hypoxia-reversal agent aimed at improving T cell access to tumors. ImmunoGenesis is currently conducting clinical trials, with IMGS-001 having recently dosed its first patient in a Phase 1a/1b trial. The company operates from JLABS @ TMC, a biotech incubator that supports their research and development efforts. Their focus on addressing the significant unmet needs in cancer care positions them as a noteworthy player in the pharmaceutical industry.

12. Iterion Therapeutics

• Website: iteriontherapeutics.com
• Ownership type: Venture Capital
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $17.0M, February 2021
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: iterion-therapeutics

Iterion Therapeutics, founded in 2014 and based in Houston, Texas, is a biopharmaceutical company dedicated to developing innovative cancer treatments. The company is focused on its lead product, tegavivint, which is a first-in-class small molecule inhibitor targeting the Wnt/beta-catenin signaling pathway. This pathway is crucial in various cancers, and tegavivint aims to address significant unmet needs in oncology by inhibiting oncogenic gene expression. Iterion is currently enrolling patients in clinical trials for hepatocellular carcinoma and has established safety and clinical activity in earlier trials. The company collaborates with healthcare providers and research institutions to enhance treatment options for patients. Iterion has also secured $17 million in Series B funding, which supports its ongoing research and development initiatives.

13. Opexa Therapeutics

• Website: opexatherapeutics.com
• Ownership type: Corporate
• Headquarters: The Woodlands, Texas, United States (USA)
• Employee distribution: United States (USA) 68%, India 32%
• Latest funding: September 2017
• Founded year: 1986
• Headcount: 11-50
• LinkedIn: opexa-therapeutics

Opexa Therapeutics, based in The Woodlands, Texas, is a biotechnology company founded in 1986. The firm specializes in the development of personalized immunotherapies aimed at treating autoimmune diseases, with a particular emphasis on multiple sclerosis (MS) and neuromyelitis optica (NMO). Their flagship product, Tcelna®, is a personalized T-cell immunotherapy currently in Phase IIb clinical trials, specifically designed for patients with Secondary Progressive MS. Opexa's approach is rooted in precision medicine, tailoring treatments to individual patients' immune responses. The company also works on OPX-212, another autologous T-cell therapy targeting NMO. Opexa operates a cGMP facility and research laboratories, underscoring its commitment to high-quality manufacturing and development processes. Despite not having reported recent funding, Opexa remains publicly traded on NASDAQ under the ticker OPXA, indicating its ongoing presence in the market and its potential for future growth.

14. Maxwell Biosciences

• Website: maxwellbiosciences.com
• Ownership type: Venture Capital
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: United States (USA) 75%, India 12%, Canada 12%
• Latest funding: January 2023
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: maxwell-biosciences

Maxwell Biosciences, founded in 2016 and based in Austin, Texas, is a biotechnology firm dedicated to developing synthetic immune system technologies and therapeutics. The company is particularly focused on addressing infectious diseases through its Claromer® platform, which aims to create effective treatments for a range of pathogens. This platform is designed to combat the growing issue of antimicrobial resistance, a significant concern in modern medicine. Maxwell's approach leverages artificial intelligence to analyze the body's healing processes and the decline of certain peptides with age, which are crucial for immune function. The company is currently in the preclinical stage, with plans to initiate human trials for its lead drug candidate, MXB-22,510, in 2025. Their research has garnered attention and support from various prestigious institutions, including DARPA and the NIH, highlighting their involvement in the biotechnology and pharmaceutical industries.

15. Fagron US

• Website: fagron.us
• Ownership type: Private
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: United States (USA) 92%, Brazil 8%
• Founded year: 1980
• Headcount: 201-500
• LinkedIn: fagron-us

Fagron US, based in Austin, Texas, is a pharmaceutical compounding company founded in 1980. The company specializes in providing innovative compounding solutions and products tailored to the needs of pharmacists and pharmacies. Fagron US emphasizes personalized medication, aiming to enhance patient care through high-quality formulations and educational resources. With a workforce of around 62 employees, the company operates primarily in the United States, with a smaller presence in Brazil. Fagron US is involved in various initiatives to support the compounding pharmacy community, including partnerships with organizations like the Low Dose Naltrexone Research Trust and the Gates Healthcare. They also offer educational programs through Fagron Academy, which focuses on advancing the skills of pharmacists in compounding practices. Their extensive network includes over 4,000 suppliers and 406 pharmacists, showcasing their commitment to quality and customer support in the pharmaceutical industry.

16. OncoNano Medicine, Inc.

• Website: onconano.com
• Ownership type: Venture Capital
• Headquarters: Southlake, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $18.4M, October 2021
• Founded year: 2014
• Headcount: 11-50
• LinkedIn: onconano-medicine

OncoNano Medicine, Inc., founded in 2014 and based in Southlake, Texas, is a biotechnology firm dedicated to advancing cancer treatment through its proprietary nanotechnology platform. The company specializes in developing innovative oncology therapeutics aimed at improving patient outcomes by ensuring precise drug delivery to tumor sites. Their ON-BOARD™ technology leverages the acidic environment of tumors to enhance the effectiveness of therapeutic agents. OncoNano is currently involved in clinical trials, including the evaluation of ONM-501, a dual-activating STING agonist, and Pegsitacianine, a pH-sensitive fluorescent nanoprobe designed for real-time surgical imaging. The company has attracted significant venture capital funding, with its latest round raising $18.4 million in October 2021, underscoring its potential in the oncology market.

17. Vital Health Care Inc

• Website: vitalhealthcare.net
• Ownership type: Private
• Headquarters: Edinburg, Texas, United States (USA)
• Employee distribution: India 68%, United States (USA) 32%
• Founded year: 1999
• Headcount: 51-200
• LinkedIn: vital-health-care-inc

Vital Health Care Inc, founded in 1999, is a pharmaceutical manufacturer based in Edinburg, Texas. The company specializes in the production of active pharmaceutical ingredients (APIs), catering to both national and international pharmaceutical companies. Vital Health Care is particularly known for its high-quality products, including Quinine and various other medicinal compounds. The company emphasizes continuous innovation and development, which is essential for maintaining its competitive edge in the pharmaceutical industry. With a workforce that is distributed between India and the United States, Vital Health Care has built a reputation as a reliable supplier. The company has also made significant strides in exports, with nearly half of its turnover coming from international markets. Its manufacturing facilities are compliant with global standards, including WHO and USFDA guidelines, ensuring that its products meet rigorous quality requirements.

18. PanTher Therapeutics

• Website: panthertx.com
• Ownership type: Venture Capital
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: June 2023
• Founded year: 2016
• Headcount: 1-10
• LinkedIn: panther-therapeutics

PanTher Therapeutics, based in Austin, Texas, is a biotechnology firm founded in 2016. The company is dedicated to redefining cancer treatment through its innovative drug delivery systems. Their primary focus is on localized, high-dose chemotherapy treatments that aim to enhance patient outcomes in oncology. PanTher's technology platform, Sagittari™, allows for the continuous administration of potent drugs directly at the tumor site, significantly increasing drug concentration while reducing systemic exposure. This method is particularly relevant for challenging cancers, such as pancreatic cancer, where their lead product candidate, PTM-101, is currently in clinical development. The company actively engages in clinical trials and research, working closely with healthcare providers and oncologists to deliver advanced therapeutic solutions. PanTher Therapeutics has also received funding to support its initiatives, further solidifying its role in the pharmaceutical sector.

19. Renibus Therapeutics Inc

• Website: renibus.com
• Ownership type: Venture Capital
• Headquarters: Southlake, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $25.0M, September 2023
• Founded year: 2016
• Headcount: 201-500
• LinkedIn: renibus-therapeutics-inc

Renibus Therapeutics Inc, based in Southlake, Texas, is a biopharmaceutical company founded in 2016. The company is dedicated to developing innovative treatments aimed at improving outcomes for patients suffering from cardio, renal, and metabolic diseases. Their lead product, RBT-1, is a first-in-class intravenous drug designed to reduce postoperative complications in patients undergoing elective cardiac and valve surgeries. Currently in a Phase 3 pivotal trial, RBT-1 has garnered FDA Breakthrough and Fast Track Designations, highlighting its potential impact in the field. Another key product, Veverimer, is an oral hydrochloric acid binder that targets gastrointestinal issues and is being developed for several indications. Renibus is actively involved in clinical trials and has a pipeline that includes additional assets at earlier stages of development. The company has recently raised $25 million in Series B funding, further supporting its mission to transform treatment paradigms in its focus areas.

20. IntraBio Inc

• Website: intrabio.com
• Ownership type: Private
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: United States (USA) 68%, United Kingdom (UK) 32%
• Latest funding: $40.3M, March 2024
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: intrabio-inc

IntraBio Inc, founded in 2015 and based in Austin, Texas, is a private biopharmaceutical company dedicated to developing innovative therapies for rare neurodegenerative diseases. The company is particularly focused on its lead product, IB1001, which targets conditions such as Niemann-Pick Disease Type C and GM2 Gangliosidosis. IntraBio conducts clinical trials to assess the efficacy and safety of its treatments, aiming to enhance the quality of life for patients and their families. The company has a strong scientific foundation, with expertise stemming from collaborations with institutions like the University of Oxford and the University of Munich. IntraBio has also secured substantial funding, amounting to over $40 million, which supports its research and development efforts. Recently, the FDA accepted their New Drug Application for IB1001, marking a significant milestone in their journey to bring new therapies to market.

21. Jurata Thin Film

• Website: juratatf.com
• Ownership type: Venture Capital
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), September 2023
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: jurata-thin-film

Jurata Thin Film is a biotechnology firm based in Houston, Texas, founded in 2019. The company specializes in creating innovative drug delivery systems for vaccines and biologics. Their unique technology allows for the long-term storage of therapeutic agents at ambient or elevated temperatures, eliminating the need for cold chain logistics. This advancement is particularly crucial for improving vaccine accessibility in underserved areas. Jurata collaborates with healthcare providers and pharmaceutical organizations to enhance the distribution of vaccines, making life-saving therapies more accessible to populations in need. The company has received attention for its work, including a recent grant from CEPI to develop under-the-tongue films for mRNA-LNP vaccine delivery, showcasing their commitment to advancing vaccine technology.

22. Osteal Therapeutics

• Website: ostealtx.com
• Ownership type: Venture Capital
• Headquarters: Dallas, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series D, $50.0M, June 2024
• Founded year: 2013
• Headcount: 11-50
• LinkedIn: joint-purification-systems

Osteal Therapeutics is a clinical-stage pharmaceutical company based in Dallas, Texas, founded in 2013. The company is dedicated to developing novel musculoskeletal therapeutics aimed at treating orthopedic infections and their consequences. Their flagship product, VT-X7, is a drug-device combination that seeks to revolutionize the treatment of periprosthetic joint infections, a serious complication that can arise after joint replacement surgeries. Osteal Therapeutics has made significant strides in its development pipeline, having completed a Phase 2 clinical trial in late 2020. The company employs a low-risk development strategy by enhancing the delivery of established pharmaceuticals known for their safety and efficacy. Recently, Osteal Therapeutics secured $50 million in Series D funding to support the approval and commercial launch of VT-X7, reflecting strong investor interest and confidence in their innovative approach to addressing a critical healthcare issue.

23. Santa Cruz Biotechnology (SCBT)

• Website: scbt.com
• Ownership type: Private
• Headquarters: Dallas, Texas, United States (USA)
• Employee distribution: United States (USA) 87%, China 10%, Germany 4%
• Founded year: 1991
• Headcount: 201-500
• LinkedIn: santa-cruz-biotechnology

Santa Cruz Biotechnology, Inc. (SCBT), founded in 1991 and based in Dallas, Texas, is a biotechnology firm that provides a wide array of laboratory products. Their primary focus is on antibodies, gene editing tools, and various chemicals that are crucial for scientific research. SCBT serves a clientele that includes researchers and laboratories within the biotechnology and pharmaceutical sectors, supplying them with essential tools for experimentation and discovery. The company has a significant presence in the market for primary monoclonal antibodies, which are utilized in numerous assays, including Western blotting and immunostaining. Additionally, SCBT offers CRISPR products and other gene editing tools, reflecting their commitment to advancing research methodologies. Their product range also includes support products for protein analysis and a variety of laboratory supplies, making them a comprehensive resource for research needs.

24. Empower Pharmacy

• Website: empowerpharmacy.com
• Ownership type: Private
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Debt), September 2023
• Founded year: 2009
• Headcount: 1001-5000
• LinkedIn: empower-pharmacy

Empower Pharmacy, founded in 2009 and based in Houston, Texas, is a private compounding pharmacy that focuses on creating customized medications to meet the specific needs of patients. They serve healthcare practitioners and patients across the United States, offering a wide range of compounded products that address various health concerns, including men's and women's health, hormone replacement therapy, weight management, and more. Empower Pharmacy operates both a 503A compounding pharmacy and a 503B outsourcing facility, which allows them to produce medications at scale while maintaining high quality standards. Their commitment to quality is reflected in their rigorous quality control processes and their use of advanced technology in their operations. Empower Pharmacy is also dedicated to expanding access to affordable medications, ensuring that patients can receive the treatments they need regardless of their location.

25. The Woodlands Compounding Pharmacy

• Website: twcprx.com
• Ownership type: Private
• Headquarters: The Woodlands, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2008
• Headcount: 11-50
• LinkedIn: the-woodlands-compounding-pharmacy

The Woodlands Compounding Pharmacy, founded in 2008 and located in The Woodlands, Texas, is a private compounding pharmacy that specializes in creating customized medications tailored to the specific needs of patients. With a team of around 20 employees, the pharmacy focuses on providing personalized health solutions for both humans and pets. Their services include a wide range of compounded medications, vaccinations, and consultations, addressing various health conditions and preferences. The pharmacy collaborates closely with healthcare providers to ensure that patients receive medications that are not only effective but also suited to their unique requirements. This approach allows them to cater to individuals who may have allergies, sensitivities, or specific dosage needs that standard medications do not meet. The Woodlands Compounding Pharmacy also emphasizes the importance of patient education and support, ensuring that clients are well-informed about their treatment options. Their commitment to quality and personalized care positions them as a relevant player in the pharmaceutical industry.

Pharmaceuticals Companies Insights: Key Companies in Texas

Want to Find More Pharmaceuticals Companies Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!